NCT07141823 (DNA Damage) is a NA clinical trial of Vitamin C (Ascorbic Acid) regularly has been taken in Narghile, sponsored by Nora Tariq Mohammed.

Who is sponsoring NCT07141823?

NCT07141823 is sponsored by Nora Tariq Mohammed.

What drugs are being tested in NCT07141823?

Interventions in NCT07141823: Vitamin C (Ascorbic Acid) regularly has been taken.

Is NCT07141823 still recruiting?

NCT07141823 is currently completed. Last updated 26 August 2025.

Last reviewed 2025-08-26 · How we verify

NCT07141823: DNA Damage

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Oxidative DNA Damage Enhancement by Vitamin C Among Narghile Smokers and Non-smokers

Completed NA Last updated 26 August 2025

What this trial tests

NA trial testing Vitamin C (Ascorbic Acid) regularly has been taken in Narghile in 96 participants. Completed in 10 March 2025.

Timeline

15 October 2024

Primary endpoint
10 December 2024

10 March 2025

Quick facts

Lead sponsor	Nora Tariq Mohammed
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	basic science
Enrollment	96
Start date	15 October 2024
Primary completion	10 December 2024
Estimated completion	10 March 2025
Sites	1 location across Iraq

Drugs / interventions tested

Vitamin C (Ascorbic Acid) regularly has been taken

Conditions studied

Narghile — all drugs for Narghile →

Sponsor

Nora Tariq Mohammed

Who can join

Adults 18 Months to 30 Months, any sex, with Narghile. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate oxidative DNA damage among hookah smokers compared to non-smokers by measuring biomarkers of oxidative stress in blood samples. The objective is to determine the impact of hookah smoking on DNA integrity and overall oxidative status in adults.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07141823 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nora Tariq Mohammed
Last refreshed: 26 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07141823.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing